These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38527450)

  • 1. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
    Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
    Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison between
    Satoh R; Ali F; Botha H; Lowe VJ; Josephs KA; Whitwell JL
    Neuroimage; 2024 Feb; 286():120509. PubMed ID: 38184157
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
    Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O
    JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
    Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy.
    Badihian N; Gatto RG; Satoh R; Ali F; Clark HM; Pham NTT; Whitwell JL; Josephs KA
    Eur J Neurol; 2024 Aug; 31(8):e16320. PubMed ID: 38686979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased basal ganglia binding of
    Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
    Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
    Orlandi F; Carlos AF; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Stephens YC; Schwarz CG; Senjem ML; Jack CR; Agosta F; Filippi M; Dickson DW; Josephs KA; Whitwell JL
    Brain Commun; 2024; 6(2):fcae113. PubMed ID: 38660629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo
    Malpetti M; Kaalund SS; Tsvetanov KA; Rittman T; Briggs M; Allinson KSJ; Passamonti L; Holland N; Jones PS; Fryer TD; Hong YT; Kouli A; Bevan-Jones WR; Mak E; Savulich G; Spillantini MG; Aigbirhio FI; Williams-Gray CH; O'Brien JT; Rowe JB
    J Nucl Med; 2022 Jul; 63(7):1052-1057. PubMed ID: 34795013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
    Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
    Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal neuroimaging relationships in progressive supranuclear palsy.
    Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau imaging with [
    Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
    Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
    Ghirelli A; Tosakulwong N; Weigand SD; Clark HM; Ali F; Botha H; Duffy JR; Utianski RL; Buciuc M; Murray ME; Labuzan SA; Spychalla AJ; Pham NTT; Schwarz CG; Senjem ML; Machulda MM; Baker M; Rademakers R; Filippi M; Jack CR; Lowe VJ; Parisi JE; Dickson DW; Josephs KA; Whitwell JL
    Ann Neurol; 2020 Nov; 88(5):1009-1022. PubMed ID: 32869362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis.
    Jin J; Su D; Zhang J; Li X; Feng T
    J Neurol; 2023 May; 270(5):2451-2467. PubMed ID: 36633672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.